Implementation of concomitant Impella® support
Impella® (Abiomed, Danvers, Massachusetts, USA) implantation was realized either simultaneously with VA-ECMO in the heart catheter laboratory or after ECMO implantation on the intensive care unit, due to clinical findings as mentioned above.
Impella® implantation was guided by transoesophageal echocardiography. Additional Impella® therapy resulted in a target ACT of 180-220.